cilazapril, anhydrous has been researched along with Insulin Resistance in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, N; Izumi, Y; Jian, T; Kanmatsuse, K; Nakayama, M; Nakayama, T; Satoh, C; Soma, M | 1 |
| Kiselevich, A; London, D; Magen, E; Priluk, R; Viskoper, RJ; Volchek, L; Yosefy, C | 1 |
| Rosenthal, JH | 1 |
| Arakawa, K; Hirata, K; Liu, R; Saku, K; Shiomi, M; Tateishi, K; Zhang, B | 1 |
| Harano, Y; Ikebuchi, M; Shinozaki, K; Suzuki, M; Yokota, C | 1 |
| Cirić, J; Nesović, M; Tasić, N; Trbojević, B; Zarković, M | 1 |
| Hara, Y; Harano, Y; Kanazawa, A; Nishioheda, Y; Ryomoto, K; Shinozaki, K; Suzuki, M; Tsushima, M | 1 |
1 review(s) available for cilazapril, anhydrous and Insulin Resistance
| Article | Year |
|---|---|
Therapeutic experience with cilazapril.
Topics: Administration, Oral; Arteriosclerosis; Blood Pressure; Cilazapril; Double-Blind Method; Glucose Tolerance Test; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Kidney; Longitudinal Studies | 1994 |
2 trial(s) available for cilazapril, anhydrous and Insulin Resistance
| Article | Year |
|---|---|
Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity.
Topics: Administration, Oral; Albuminuria; Blood Glucose; Blood Pressure; Body Mass Index; Brachial Artery; Cholesterol, LDL; Cilazapril; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Endothelial Cells; Endothelium, Vascular; Evoked Potentials; Female; Glyburide; Glycated Hemoglobin; Heart Rate; Humans; Hyperlipidemias; Hypertension; Insulin; Insulin Resistance; Kidney; Male; Rosiglitazone; Simvastatin; Skin Physiological Phenomena; Sympathetic Nervous System; Thiazolidinediones; Time Factors; Ultrasonography; Vasodilation | 2004 |
Therapeutic experience with cilazapril.
Topics: Administration, Oral; Arteriosclerosis; Blood Pressure; Cilazapril; Double-Blind Method; Glucose Tolerance Test; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Kidney; Longitudinal Studies | 1994 |
5 other study(ies) available for cilazapril, anhydrous and Insulin Resistance
| Article | Year |
|---|---|
Leukocyte angiotensin II levels inpatients with essential hypertension:relation to insulin resistance.
Topics: Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Body Mass Index; Chromatography, High Pressure Liquid; Cilazapril; Female; Homeostasis; Humans; Hypertension; Insulin; Insulin Resistance; Leptin; Leukocytes; Male; Middle Aged | 2003 |
Quantitative characterization of insulin-glucose response in Watanabe heritable hyperlipidemic and cholesterol-fed rabbits and the effect of cilazapril.
Topics: Animals; Blood Glucose; Cholesterol, Dietary; Cilazapril; Glucose; Glucose Tolerance Test; Hyperlipidemias; Injections, Intravenous; Insulin; Insulin Resistance; Rabbits | 1994 |
Normalization of insulin resistance in non-obese essential hypertension by cilazapril treatment.
Topics: Antihypertensive Agents; Catecholamines; Cilazapril; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin Resistance; Lipids; Male; Middle Aged; Obesity | 1995 |
[The effect of cilazapril and prazosin on insulin sensitivity in patients with essential hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Obesity; Prazosin | 1995 |
Clinical impact of insulin resistance syndrome in cardiovascular diseases and its therapeutic approach.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Cilazapril; Humans; Insulin Resistance; Middle Aged; Quinazolines | 1996 |